# Montelukast Sodium

NDC: 65862-567
Generic name: Montelukast Sodium
Labeler / Manufacturer: Aurobindo Pharma Limited
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, CHEWABLE
Routes: ORAL
Marketing started: 20120803

FDA application: ANDA202096

## Active ingredients

- MONTELUKAST SODIUM: 4 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"65862-567"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=65862-567
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ba42b0a9-83f1-4283-a853-f99cdd0761b9